Vaginal Vitamin E for Dryness: What the Suppository and Cream Studies Tested

“Vitamin E for vaginal dryness” can refer to several very different products. The research below tested preparations made for vaginal use, with doses and ingredients specified by the investigators. It did not test skin oil or capsules sold to swallow.

The placebo comparison used a laboratory-made suppository

The 2013 placebo comparison in Ahvaz, Iran, randomized 44 women aged 45–65; 42 completed it, including 20 in the vitamin E group and 22 taking placebo. Two vitamin E participants were excluded for missed follow-up or not taking the product. Vaginal infection and unexplained bleeding were among the exclusions.¹

Both suppositories used a semisynthetic fatty-acid triglyceride base; the active preparation added 1 mg vitamin E. Participants used one daily for two weeks, then every other day through week eight.¹

Mean symptom scores at eight weeks were 0.65 with vitamin E and 5.95 with placebo, favoring vitamin E. The 0–12 composite score combined irritation, itching, dryness and pain with sex. These were group averages across four symptoms, not percentages of women whose dryness disappeared.¹

Table 1 reports baseline means of 4.65 and 6.95, with standard deviations of 2.41 and 1.58, alongside P = 0.431. Those figures appear inconsistent; we could not resolve the reporting problem. Results do not establish benefit for unexplained itching or bleeding, or another formulation.¹

Hyaluronic acid performed better in another comparison

The 2012 hyaluronic-acid comparison, also in Ahvaz, analyzed 40 completers. Laboratory-prepared suppositories contained either 1 mg vitamin E or 5 mg hyaluronic acid sodium salt, in a semisynthetic fatty-acid base. The schedule was daily for two weeks, then three days a week, for eight weeks.²

Both groups improved. The reported final composite symptom scores were 0.65 for vitamin E and 0.15 for hyaluronic acid; lower was better, and the between-group comparison favored hyaluronic acid.²

This study compared two active formulations without a placebo. It does not show that every hyaluronic-acid product beats every vitamin E product, or that a larger vitamin E dose would have changed the result.²

Four published reports may not mean four independent groups

A 2022 systematic review included four reports, all from Iran. It identified possible participant overlap: the two Ahvaz publications had similar recruitment periods and identical vitamin E group sizes and final symptom scores. Two estrogen-comparison reports also had matching participant counts and similar recruitment periods and characteristics.³

The reviewers could not obtain clarification from the study authors. The overlap remains a question, rather than a confirmed duplicate dataset. Counting every report as independent confirmation would ignore it.³

The two 12-week estrogen comparisons each reported 52 women, testing 100 IU vitamin E suppositories against conjugated-estrogen cream. They found no significant between-group difference in their respective sexual-function and quality-of-life measures. Small comparisons with different symptom scales cannot establish that the treatments are interchangeable. The review could not identify an ideal dose or long-term safety.³

A newer cream trial reported symptoms and side effects

The 2023 cream trial⁴ randomized 72 women aged 45–56 with vaginal atrophy and overactive-bladder symptoms in Ahar, Iran. The pharmacy laboratory prepared vitamin E cream with 100 IU in half an applicator; the comparator provided 0.3 mg conjugated estrogen. Use was nightly for one week, then twice weekly through eight weeks.⁴

Vaginal symptom scores improved in both groups, with no significant difference after adjustment for baseline scores. There was no placebo arm, so improvement within a group cannot isolate the ingredient’s effect from the cream base or other influences.⁴

The results section reports three cases of abdominal pain, one of itching and one of burning with vitamin E. All were described as tolerable. The paper’s concluding claim of no side effects conflicts with those reported events.⁴

Women with breast cancer, estrogen-related cancer, vaginal bleeding or anticoagulant use were among those excluded. Its conclusion proposing an alternative for women unable to use hormones does not establish safety for these excluded groups.⁴

The 500 mg ovules were studied without a control group

The 2024 ovule report examined records from 50 women aged 50–70, including premenopausal and menopausal groups, treated in one Italian center. They used a commercial vaginal ovule containing 500 mg tocopherol acetate each evening for 14 days.⁵

The authors reported symptom improvement, but the study was retrospective and had no untreated or placebo comparison. It cannot establish that the ovule caused the improvement or that this preparation is more effective than the lower-dose preparations.⁵

Bring the exact product to the treatment discussion

In England, current NICE⁶ guidance considers nonhormonal vaginal moisturizers or lubricants when vaginal estrogen is contraindicated or someone would prefer not to use it. It also describes prescription options when initial treatments do not help. For persistent symptoms during aromatase-inhibitor treatment for breast cancer, it calls for work with a breast cancer specialist to identify options.⁶

If you are considering vitamin E, bring the package to a pharmacist or clinician. Ask whether it is intended for vaginal use, how its formulation compares with the studies, and when to review symptoms if it does not help. The milligrams or IU on a label alone cannot answer those questions.

The NHS⁷ advises against creams, lotions or moisturizers not made for the vagina, because they can cause irritation or infection. Seek assessment if dryness persists for a few weeks despite self-care, affects daily life, or comes with unusual discharge. Bleeding after sex or after menopause also needs a check.⁷

Our vaginal moisturizer and lubricant guide explains their different uses. Chapter 8, “Dry Spells,” in Down There, Decoded includes “Lube, Explained” and “What the Prescription Options Are” for discussing everyday dryness and treatment choices.